What is SANUWAVE?
SANUWAVE is a medical technology firm dedicated to the development and commercialization of noninvasive energy transfer solutions designed to enhance advanced wound healing. The company leverages its proprietary ultrasound-based systems to stimulate the body's inherent regenerative processes, addressing complex and chronic wounds. SANUWAVE's approach prioritizes patient comfort and clinical efficacy, aiming to improve the quality of life for individuals suffering from difficult-to-treat wounds through safe, efficient, and pain-free therapeutic interventions.
How much funding has SANUWAVE raised?
SANUWAVE has raised a total of $28.7M across 6 funding rounds:
Debt
$2M
Debt
$3M
Debt
$350K
Debt
$1M
Unspecified
$12M
Other Financing Round
$10.3M
Debt (2012): $2M, investors not publicly disclosed
Debt (2017): $3M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Debt (2021): $1M featuring PPP
Unspecified (2022): $12M, investors not publicly disclosed
Other Financing Round (2024): $10.3M, investors not publicly disclosed
What's next for SANUWAVE?
The recent major strategic investment positions SANUWAVE for significant growth and further development of its patented wound care technology. This infusion of capital is expected to accelerate market penetration, enhance research and development efforts, and potentially expand the company's product portfolio. SANUWAVE's focus on noninvasive, regenerative medicine aligns with a growing trend in healthcare towards less invasive and more effective treatment modalities, suggesting a promising trajectory for the company as it scales its operations and seeks to capture a larger share of the advanced wound care market.
See full SANUWAVE company page
